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ABSTRACT The speciﬁc recognition of carbohydrates by lectins plays a major role in many cellular processes. Galectin-1
belongs to a family of 15 structurally related b-galactoside binding proteins that are able to control a variety of cellular events,
including cell cycle regulation, adhesion, proliferation, and apoptosis. The three-dimensional structure of galectin-1 has been
solved by x-ray crystallography in the free form and in complex with various carbohydrate ligands. In this work, we used a combi-
nation of two-dimensional NMR titration experiments and molecular-dynamics simulations with explicit solvent to study the mode
of interaction between human galectin-1 and ﬁve galactose-containing ligands. Isothermal titration calorimetry measurements
were performed to determine their afﬁnities for galectin-1. The contribution of the different hexopyranose units in the protein-
carbohydrate interaction was given particular consideration. Although the galactose moiety of each oligosaccharide is necessary
for binding, it is not sufﬁcient by itself. The nature of both the reducing sugar in the disaccharide and the interglycosidic linkage
play essential roles in the binding to human galectin-1.INTRODUCTION
Carbohydrates are involved in a wide range of cellular
processes, including cell recognition, cell adhesion, and cell
differentiation, and are considered as the third class of
information-encoding biological macromolecules (1). Their
biological activities are usually mediated by their interactions
with proteins at the surface of cells (2). Mammalian glycans
rely on a group of 10 common monosaccharide units, result-
ing in a large number of possible hexasaccharides, of which
2000 structures of N-linked glycans are known. The
complexity of the glycome is increased by themode of attach-
ment to glycoproteins and by further chemical modification,
such as methylation, sulfation, acetylation, and phosphoryla-
tion. This diversity poses a real challenge to investigators
attempting to study the role of glycosylation in biological
phenomena (3). In addition, the flexibility of oligo- and poly-
saccharides allows them to adapt to a variety of interactions in
biological recognition processes (4). Therefore, character-
izing the dynamic properties of carbohydrates in complex
with their binding partners is a crucial step toward gaining
a better understanding of carbohydrate recognition.
Galectins constitute a class of carbohydrate-binding
proteins (lectins) that share both a conserved sequence in the
carbohydrate recognition domain (CRD) and an affinity for
b-galactosides. They are found in all taxa of the living world.
The galectin family is composed of 15 members subdivided
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0006-3495/09/12/3168/10 $2.00into three categories: 1), the prototype (galectin-1, 2, 5, 7, 10,
11, 13, 14, and 15); 2), the tandem repeat characterized by
the presence of two distinct CRDs joined by a linker peptide
(galectin-4, 6, 8, 9, and 12); and 3), the chimera type, repre-
sented by the only member, galectin-3 (5).
All galectin ligands share a b-galactose moiety at the
nonreducing end (6–8). However, biochemical studies have
demonstrated that there is a higher level of complexity
involved for carbohydrate recognition by the galectins than
just the primary requirement of the galactose sugar. The
oligosaccharide interaction can be very specific, as various
galectins interact with a different range of galactose oligo-
saccharide ligands (2,9). Studies indicating that galectins
are implicated in cancer development (10–12) have opened
the way for the development of new therapeutic strategies
to combat cancer (13–16). Gaining a detailed description and
understanding of the protein-carbohydrate interaction is
a key step in the development of new drugs.
The structure of galectin-1 has been characterized by x-ray
crystallography (17) as a dimer containing two identical
monomers related by a twofold symmetry axis. The folding
of the homodimer involves a b-sandwich that consists of two
antiparallel b-sheets as found in most carbohydrate-binding
modules (18). The same b-sheets are in continuity in the
dimer and make two mega b-sheets stabilizing the dimer.
The dimer interface is formed by the N- and C-terminal of
each monomer. The structure of galectin-1 has been solved
in complex with various oligosaccharides, revealing a highly
conserved core-binding site for lactose, N-acetyllactosamine,
and biantennary saccharides of N-acetyllactosamine with
features in agreement with specificity studies (19,20). The
doi: 10.1016/j.bpj.2009.09.026
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FIGURE 1 Surface representation of the CBS of human
galectin-1. (A) The binding site can be divided into five
subsites (subsites A–E) that can interact with the oligosac-
charide ligands (21). The subsites are defined as follows:
subsiteA:Tyr-119,Ala-121,Ala-122, andAsp-123 (green);
subsite B: Val-31, Leu-32, Asn-33, Leu-34, and Gly-35
(pink); subsite C: His-44, Phe-45, Asn-46, Arg-48, His-52,
and Trp-68 (blue); subsite D: Gly-53, Asp-54, Val-59,
Asn-61, Glu-71, and Arg-73 (orange); and subsite E:
Gly-69 and Thr-70 (gray). An N-acetyllactosamine oligo-
saccharide ligand is shown inside the CBS to illustrate the
binding to subsites C and D of the disaccharide in x-ray
structures of galectin-1. (B) Detail of the interaction between
the carbohydrate ligand and the protein. Residues from
subsites C and D are highlighted. Hydrogen bonds are
shown as dashed green lines. (PDB structure 1W6P from
Lopez-Lucendo et al. (17).)carbohydrate-binding sites (CBS) are located at the top of
each monomer on the same face of the dimer. Each CBS is
formed by a cavity that is approximately long enough to
hold a linear tetrasaccharide (Fig. 1). One can schematically
describe the galectin CBS as having five subsites (subsites
A–E), which is supported by its specificity for small saccha-
rides (9,21). In this model, subsite C corresponds to the
actual b-galactoside-binding site of the galectins, and subsite
D contributes to the second part of the conserved core disac-
charide-binding site (Fig. 1). The shape of the binding site
varies among galectins, suggesting that the same extensions
would not be bound equally by the different galectins. More-
over, there are also variations in binding preference on the
reducing side of the terminal galactose residue correspond-
ing to subsites D–E in Fig. 1 (21). The structurally less
defined subsite E can accommodate possible interactions
with moieties linked at the reducing end of the saccharide
in subsite D.
The carbohydrate-galectin interaction is characterized by
a stacking interaction between the sugar ring and an aromatic
residue in the protein-binding site, and by a series of specific
hydrogen bonds between polar groups of the sugars and
protein backbone and side-chain atoms (22–24). In the
case of galectin-1, the main interaction involves a hydrogen
bond between His-44 and Arg-48 with O4 of galactose
residue. Aromatic residue Trp-68 is conserved within the ga-
lectin family and is responsible for positioning the carbohy-
drate ligand inside the cavity through a stacking interaction
(17). The presence of an aromatic amino acid residue (Trp,
Tyr, or Phe) near the nonpolar face of galactose is a common
feature of galactose-binding lectins (24).
In a previous study, molecular dynamics (MD) simulations
of bovine galectin-1 in complex with several N-acetyllactos-
amine-containing ligands were performed (25). The MD
results indicated that bovine galectin-1 can accommodate
different oligosaccharidic substituents at the nonreducing
terminus of the oligosaccharide extending into the remainder
of a characteristic surface groove (subsite B). Here, we used
MD simulations in explicit water with a combination of the
Charmm-22 (26) and GLYCAM06 (27) parameter sets toinvestigate the binding of galactose monosaccharide and
four galactose-containing disaccharides to human galectin-1.
The disaccharides differed in terms of the nature of the
reducing unit (Glc, GlcNAc, or GalNAc) and interglycosidic
linkage between the two sugars (b1/4/b1/3).We analyzed
the MD trajectories in the light of NMR and isothermal
titration calorimetry (ITC) data by monitoring structural and
energetic properties such as atom and residue fluctuations,
hydrogen bonds, the stability of the ligands within the cavity,
and the interaction energy between the carbohydrates and
galectin-1 residues. The analysis of the different trajectories
revealed that MD simulations could be used to discriminate
between high-affinity ligands (such as lactose,N-acetyllactos-
amine, and lacto-N-biose) and low-affinity ligands (such as
galactose and galacto-N-biose), and to determine the contribu-
tion of the different hexopyranose units of the oligosaccharide
to the binding of human galectin-1.
MATERIALS AND METHODS
Galectin-1 expression and puriﬁcation
A construct including a 6-His sequence added at the C-terminal extremity of
galectin-1 was obtained. His6-galectin-1 was overexpressed in Escherichia
coli M15. Protein production was induced using 1 mM isopropyl-b-D-
thiogalactopyranoside for 4 h after growing to OD600nm 0.6. Recombinant
galectin-1 was purified using a cobalt affinity column (TALON metal
affinity). The protein was eluted with the use of imidazole buffer (150 mM).
Galectin-1 was dialyzed overnight in the appropriate buffer for NMR or
ITC experiments. 15N-labeling of the protein was achieved with the use of
15N-ammonium chloride added to M9 media.
Chemical compounds
D-galactose was obtained from Prolabo, D-lactose, and N-acetyl-D-lactos-
amine were obtained from Sigma (www.sigmaaldrich.com, Saint Quentin
Fallavier, France), and galacto-N-biose (N-acetyl-neogalactosamine) and
lacto-N-biose (N-acetyl-neolactosamine) were purchased from Dextra-Labs
(www.dextra-labs.co.uk, Readding, UK).
NMR experiments
NMR experiments were performed on a 500 MHz Avance III Bruker spec-
trometer equipped with a QXI probe. The recent full assignment of humanBiophysical Journal 97(12) 3168–3177
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drate ligands (28). NMR titrations of the complex formation were performed
by recording 15N-1H heteronuclear single quantum coherence (HSQC) using
a 0.1 mM 15N-labeled galectin-1 sample in 10 mM phosphate buffer at pH
6.0. The interaction was mapped by comparing chemical shifts of bound and
unbound protein. The spectral widths were 2000 Hz for 1H and 2027 Hz for
15N;1024data points in t2 and64 transients for eachof 128 t1pointswere used.
ITC analysis
The isothermal titration microcalorimetry experiments were performed
using a 2277 Thermal Activity Monitor calorimeter (Thermometric,
Sweden) at 298 K with a 100 mL Hamilton injection syringe. The microcal-
orimeter was dynamically calibrated at the beginning of each experiment.
Data acquisition and analyses were carried out using DIGITAM 4.1 software
(Thermometric, Sweden). In a typical titration experiment, small aliquots
(3–4 mL) of concentrated sugar dissolved in phosphate buffer (60 mM,
pH 7.6) were injected into the calorimeter reaction vessel (900 mL) contain-
ing galectin-1 (200 mM) dissolved in the same buffer. Except for galactose
(200 mM), the concentrated solutions for the other sugars were 20 mM. The
enthalpy of interaction between galectin-1 and sugar was corrected by
measuring the enthalpy change after injection of the sugar solution into
buffer solution using identical procedures and experimental conditions.
The heat released by galectin-1 dilution is negligible.
MD simulations
Programs used
All MD simulations were performed with the CHARMM package version
33b1 and force-field CHARMM version 22 (29,30) using a Dell precision
380 or a Linux cluster composed of eight biprocessors with hyperthreading
technology. VMD was used for visualization and analyses.
Initial x-ray structures
Several x-ray structureswere characterized for theunbound state of galectin-1.
The C2S mutant was used because of the availability of crystallographic
data of the protein, as well as many protein complexes with different ligands.
We used a structure previously solved at a resolution of 1.65 A˚ (PDB ID:
1W6N) by Lopez-Lucendo et al. (17). As initial structures to study protein-
sugar interactions,we also used the structures of galectin-1 bound to galactose
(1W6M), lactose (1W6O), andN-acetyllactosamine (1W6P) characterized by
the same authors. Carbohydrates exist as amixture ofa andb anomers in solu-
tion; however, in silico the anomer is fixed. We used the anomer found in the
x-ray structure; therefore, the b anomer for galactose and lactose and the
a anomer for N-acetyllactosamine were used in all simulations. In the case
of lacto-N-biose (Gal-b-1,3-GlcNAc) and galacto-N-biose (Gal-b-1,3-Gal-
NAc), for which no three-dimensional (3D) data were available, we generated
the initial complexes by superimposing the nonreducing terminal galactose
moieties in the 1W6P complex (N-acetyllactosamine), and thus used the
same anomer as for N-acetyllactosamine (a). Galectin-1 structures were
solved as a dimer (two molecules were present in the asymmetric unit), and
only coordinates corresponding to chain A were used in the MD simulations.
Nonprotein derivatives such as b-mercapto-ethanol and SO4 ions were not
taken into account. S-hydroxy-cysteine was manually modified to cysteine.
Protonation of histidine and orientation of the side chains of Asn, Gln, and
His residues were checked manually and using the WHAT IF web interface
(http://swift.cmbi.kun.nl/). Residues His-44 and His-52 were assigned to
HSP and HSD types, respectively. Crystallographic water molecules within
3 A˚ of the protein monomer were included in the initial model. All hydrogen
atoms were included explicitly in the calculation. Coordinates of missing
hydrogen atoms were added using the hbuild algorithm in CHARMM.
The galectin-1 complexes were solvated using a 63  63  63A˚3 cubic
water box of previously equilibrated TIP3 molecules, leading to a total
average of ~7200 water molecules (depending on the complex). Finally,
sodium ions were added to ensure a neutral system.Biophysical Journal 97(12) 3168–3177Energy minimization
Unfavorable contacts were removed by 3000 steps of energy minimization
with conjugate gradient. Harmonic constraints were applied and decreased
gradually from 100 to 0 kcal/mole $ A˚2 to allow smooth minimization. In
the first 1000 cycles, protein atoms were not allowed to move. We used the
switch function for the van der Waals energy and electrostatic interactions
with cuton, cutoff, and cutnb values of 9, 11, and 13 A˚, respectively.
MD simulations
MD simulations were performed using Charmm-22 (26) parameters for
proteins, and the GLYCAM06 parameters (27) for carbohydrates. Carbohy-
drate topology and parameter files were obtained in CHARMM format using
the GLYCAM-Web carbohydrate builder (http://www.glycam.com/). Using
this interface, it was possible to generate files for CHARMM MD simula-
tions that were based on the GLYCAM force field.
The Shake algorithm was applied to all hydrogen-containing bonds (31),
and a 1 fs integration step was used. The simulation used the periodic
boundary condition approximation.
A typical trajectory was prepared as follows: The minimized initial struc-
tures were heated gradually to 300 K (30 ps), equilibrated (75 ps), and finally
subjected to free MD (z2 ns). Snapshots of the coordinates were saved
every 500 steps (0.5 ps), leading to ~4000 instantaneous conformations for
each trajectory. At least two independent trajectories were generated for
each complex. A typical 2 ns simulation required ~3 weeks CPU time on
a 3.5 GHz processor.
MD analyses
Trajectories were analyzed using a combination of CHARMM, in-house-
written Perl scripts, and the VMD package. Overall root mean-square
deviation (RMSD) variations were computed with CHARMM after superim-
position of the CA atoms of galectin-1. Hydrogen bondswere identified using
CHARMM scripts and a 3.0 A˚ cutoff. The interaction energies correspond to
CHARMM energies (i.e., van der Waals and electrostatic interactions). The
orientation of galactose in the CBS was measured as follows: 1), the orienta-
tion at the end of the equilibration step was used as reference; 2), all of the
structures generated during the trajectory were superimposed onto the CA
atoms of galectin-1; and 3), the angle between the vector formed by galactose
atoms C1–C4 in the current structure and the reference was determined. The
dihedralF/J torsion angles were defined as (H1
0-C10-O-C3/C10-O-C3-H3 and
H1
0-C10-O-C4/C10-O-C4-H4) for 1/3 and 1/4 interglycosidic linkages,
respectively. The size of the binding site was estimated by measuring the
distance between the center of geometries of CA atoms belonging to residues
Asn-50,His-52, andAla-55 on the one hand, and residues Ser-62,Gly-65, and
Trp-68 on the other hand. Structural figures (Fig. 1; see Fig. S8 in the Support-
ing Material) were generated with PyMOL software (http://pymol.
sourceforge.net/).
RESULTS AND DISCUSSION
MD simulations
To investigate the characteristics of the binding of galectin-1
with various carbohydrates, we performed MD analyses of
free galectin-1 and various lectin-carbohydrate complexes
(Fig. S1 and Fig. S2).
MD free galectin-1
Galectin-1 (1W6N) was characterized as a dimer (17).
However, since the two binding sites exhibit nearly identical
structural properties, in the simulation studies we were able
to focus on the protein-carbohydrate interaction of a single
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FIGURE 2 Overall fluctuation of CA atoms (left) and average structure (right) of galectin-1 for the different trajectories: (A) free galectin-1, (B) galectin-1
bound to galactose, (C) lactose, (D) N-acetyllactosamine, (E) lacto-N-biose, and (F) galacto-N-biose. Residues in close contact with the oligosaccharide ligand
are shown as sticks and labeled. The carbohydrate ligand is shown as orange sticks. In the case of galacto-N-biose, two average conformations corresponding to
two different populations of ligands during the trajectory are indicated as orange and pink sticks, respectively. Hydrogen bonds are indicated as green dashed
lines.subunit. All MD simulations were then performed on a galec-
tin-1 monomer solvated in a water box with periodic condi-
tions. MD simulations of unbound galectin-1 monomer were
performed first. The system was heated to 300 K and equil-
ibrated before a free MD production run. The structure of the
binding site at the end of the equilibration is shown in
Fig. S3. At least two independent trajectories of 2 ns each
were generated. The same procedure was used for the
different simulations with galectin-1 bound to the various
oligosaccharides. The results of the two independent trajec-
tories were combined together to yield better statistics (32).
The binding site is fairly well defined in the free protein
and experiences only minor movements upon complexation.
Monitoring of the overall RMSD fluctuation of CA atoms
during the trajectory showed that the galectin-1 3D structure
was stable throughout the whole trajectory (Fig. S4).
Analysis of the overall residue fluctuation during the time
course of the simulation revealed that galectin-1 is a rigid
structure (Fig. 2 A) because its overall fold is maintained
by a network of hydrogen bonds within the two main
b sheets. Apart from the N- and C-termini, the highest flex-
ibility was observed within the two loops surrounding theCBS (residues 51–53 on one side and residues 64–66 on
the other side). These loops surrounding subsites C and D
(Fig. 1) contain glycine residues, which could account for
their higher flexibility.
Galectin-1 was crystallized in complex with different
galactoside-containing oligosaccharides, namely, galactose,
lactose, andN-acetyllactosamine (1W6M, 1W6O, and 1W6P,
respectively). These x-ray structures were used as initial
conformations to study protein-carbohydrate interactions
by MD.
MD of galectin-1 with galactose
Because human galectin-1 belongs to the galactose-binding
protein family, we first studied its interaction with galactose
alone (1W6M).MD simulations were performed as described
for unbound galectin-1. The overall RMSD fluctuation of
galectin-1 CA atoms during the trajectory indicated that the
overall structure was maintained during the time course of
the simulations (Fig. S4). The average residue fluctuation
was calculated and showed no major differences compared
to free galectin-1 (Fig. 2B). The interaction between galactoseBiophysical Journal 97(12) 3168–3177
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FIGURE 3 Hydrogen-bond network between galectin-1
and galactose (A), lactose (B), N-acetyllactosamine (C),
lacto-N-biose (D), and galacto-N-biose during the trajec-
tories.and theCBSwas analyzed over the full trajectories to evaluate
the stability of the carbohydrate in the binding site. Hydrogen
bonds with galactose O4 atom (His-44 and Arg-48), O5
(Arg-48), and O6 (Asn-61 and Glu-71) were observed
throughout the simulations (Fig. 3A). However, the hydrogen
bond between galactose O4 and His-44 was only observed
60% of the time, suggesting that the interaction with
galactose was not highly stable. As an illustration, the orien-
tation of galactose in the CBS was monitored, and the results
showed that the monosaccharide was not stabilized in the
CBS—it moved away from the initial binding conformation
andwas able to rotate freely due to the lack of stabilizing inter-
actions (Fig. S5). Finally, the interaction energy between
galactose and galectin-1 was computed with CHARMM,
giving an average energy of 37 5 9 kcal.mol1 with a
large fluctuation during the timescale of the simulation
(Fig. S6).
MD simulations indicate that although the galactose is
essential for oligosaccharide binding to human galectin-1,
it cannot bind efficiently by itself. Therefore, we considered
the interaction with some galactose-containing disaccharides
to study the contribution of the hexopyranose unit on the
reducing end of the galactose. For this, we used lactose
(Galb1-4Glc), N-acetyllactosamine (Galb1-4GlcNAc), and
galacto-N-biose (Galb1-3GalNAc), which differ in terms of
the nature of the reducing sugar unit (Fig. S1 and Fig. S2).Biophysical Journal 97(12) 3168–3177Importance of the reducing sugar unit
MD of galectin-1 with lactose, N-acetyllactosamine
The 3D structures solved by x-ray diffraction were used as
initial conformations of the complex (1W6O and 1W6P for
lactose and N-acetyllactosamine complexes, respectively).
The simulations were carried out as described above. In both
cases, the overall RMSD variations showed the stability of
the structure during the trajectory (Fig. S4). The loops
surrounding the active site were stabilized during the simula-
tions by the addition of a second sugar to the galactose
moiety, as indicated by the average residue fluctuation, espe-
cially for loop Ala-51–Asp-54 (Fig. 2, C and D, for lactose
and N-acetyllactosamine, respectively).
Hydrogen bonds with OH groups at positions 4 and 6, and
O5 of the galactose moiety were maintained in the interaction
with both lactose and N-acetyllactosamine (Fig. 3, B and C).
However, these interactions were more stable in the case of
lactose and N-acetyllactosamine derivatives than with galac-
tose alone (Table S1). Additional stable hydrogen bonds
between Asn-61 and galactose 06 were observed with the
two disaccharides studied. Furthermore, the reducing sugar
(glucose or N-acetyl-glucosamine) was involved in hydrogen
bonds with Arg-48 (subsite C), Glu-71, and Arg-73 (subsite
D) at positions O3 and O4. Lactose and N-acetyllactosamine
were stabilized in the CBS during the simulations and
Galectin-1/Oligosaccharide Complexes 3173constant cavity size was maintained during the whole trajec-
tory (Fig. S5). Contrary to what was observed with the galac-
tose monosaccharide, the two disaccharides were well
maintained in the CBS during the time course of the simula-
tions. The trajectories displayed stable protein-carbohydrate
complexes. The stability of the disaccharide was assessed
by monitoring V andJ torsion angles of the interglycosidic
linkage (Fig. 4,magenta and red). These dihedral angles were
stable throughout the simulations with values of ~60 and 20
for V and J, respectively, which correspond to low-energy
conformations of the disaccharides as reported previously
(33). Interaction energies between galectin-1 and the two
disaccharides were computed with CHARMM (Fig. S6) and
are in the same range for lactose (79 5 3 kJ.mol1) and
N-acetyllactosamine (755 3 kJ.mol1).
MD with galacto-N-biose
In the case of galacto-N-biose (N-acetyl-neogalactosamine),
no structural information about the complex was known.
FIGURE 4 Stability of the different disaccharide sugars in the CBS. Vari-
ation of the F (A) and J (B) torsion angles for the interglycosidic bond
during the time course of the trajectory (lactose, magenta; N-acetyllactos-
amine, red; lacto-N-biose, gold; and galacto-N-biose, light blue). Three
out of four disaccharides are stable during the whole trajectory, with F
and J angles of ~60 and 20, respectively. In contrast, a larger variation
of these torsion angles is observed with galacto-N-biose, and different
conformations can be observed. As an illustration, two orientations of gal-
acto-N-biose relative to the conserved tryptophan residue are shown in stick
representation.A complex was generated by fixing the galactose ring of gal-
acto-N-biose in the position defined by the x-ray structure of
the galectin-1/N-acetyllactosamine complex (1W6P), and
a minimized binding conformation was found. The different
trajectories were performed and analyzed as described above.
The overall RMSD variation was similar to that of the previ-
ously studied saccharides (Fig. S4). Overall, galacto-N-biose
behaved like galactose monosaccharide, as it was not stabi-
lized in the binding site. The overall fluctuation showed
a high flexibility of the loops surrounding the CBS, especially
near residueHis-52 (Fig. 2). At least two different populations
of conformations could be observed during the different simu-
lations (Fig. 2). Most hydrogen bonds were not preserved
(Fig. 3D and Table S1), especially for the N-acetyl-galactose
reducing moiety, which mainly interacted with water at the
end of the simulation, rather than with galectin-1 residues.
As a consequence, this disaccharide was not strongly bound
to galectin-1 and was able to move inside the binding site.
Analysis of theF andJ dihedral angles showed a larger fluc-
tuation of these torsion angles and revealed that the disaccha-
ride could adopt alternate conformations due to the lack of
stabilization of the sugar in the CBS (Fig. 4). The average
interaction energy of 355 5 kJ.mol1 found between ga-
lectin-1 and galacto-N-biose indicates a weak binding
(Fig. S6).
All hydrogen bonds between galectin-1 and the reducing
glucose moiety observed in the presence of lactose and
N-acetyllactosamine are lost in the interaction with galacto-
N-biose (Table S1). The nature of the sugar on the reducing
end of the galactose is important because glucose derivatives
(Glc and GlcNAc) enhance binding by increasing the number
of stable hydrogen bonds between the ligand and the protein.
Importance of the interglycosidic linkage
MD with lacto-N-biose
We performed MD simulations starting with lacto-N-biose
(neolactosamine), which only differs from N-acetyllactos-
amine by the nature of the interglycosidic linkage (b1–3 vs.
b1–4). Because no data were available for the structure of the
complex, the ligand was docked in the CBS by superimposing
the galactose moiety in the galectin-1/N-acetyllactosamine
complex (1W6P). The newly formed protein-carbohydrate
complex was then gradually minimized and subjected to MD
as described for other galectin-sugar complexes. The different
trajectorieswere analyzed asmentioned above and showed that
lacto-N-biose behaved like lactose and N-acetyllactosamine.
Although we started with a complex obtained by docking
lacto-N-biose in the binding site, rather than with an x-ray
structure, the disaccharide was bound tightly in the CBS in
a similar manner to N-acetyllactosamine. The overall fluctua-
tion showed that residues within loop Ala-51–Asp-54 were
stabilized by the interaction with the disaccharide (Fig. 2).
The stabilization was mainly due to the network of hydrogen
bonds between galectin-1 and lacto-N-biose (Fig. 3 E andBiophysical Journal 97(12) 3168–3177
3174 Meynier et al.Table S1). The profile of hydrogen bonds observedwas similar
to that seen with lactose and N-acetyllactosamine. It is inter-
esting to note, however, that the different interglycosidic
linkage leads to a completely different orientation of the
reducing GlcNAc sugar moiety between lacto-N-biose and
N-acetyllactosamine (34). The hydrogen-bonding patterns
showed that the bonds between residues Glu-71 and Arg-73
of human galectin-1 and the O3 atom of the GlcNAc unit of
N-acetyllactosaminewere lost in the case of theb(1–3) linkage;
instead, the hydroxyl group at position O4 formed hydrogen
bonds with the protein (Table S1). The conformational proper-
ties of lacto-N-biose around the interglycosidic bond were
similar to those of lactose and N-acetyllactosamine, as indi-
cated by F and J torsion angles (Fig. 4). The ensemble of
major conformations observed correspond to a low-energy
population in solution (35). In addition, the size of the binding
site was maintained almost constant during the entire simula-
tion (Fig. S5). The interaction energy between galectin-1 and
lacto-N-biose was in the same range as for the N-acetyllactos-
amine (81 5 2 kJ.mol1; Fig. S6). Lacto-N-biose only
differs from galacto-N-biose by the configuration of the OH
group in position 4 of the reducing sugar (Fig. S1 and
Fig. S2). This hydroxyl group forms hydrogen bonds with
Arg-48 andArg-73 in the complexwith lacto-N-biose,whereas
no stable interaction was detected with galacto-N-biose.
It is worth pointing out that the type of disaccharide (b1–3
or b1–4 linked) in subsite C and D determines the direction of
the glycosidic bond leading into subsite E, and may thereby
play a role in determining specificity, even in cases where
the two disaccharide types bind with similar affinity by them-
selves. To address this point, the position of the hemiacetal
OH group at the reducing end of the carbohydrate was moni-
tored for the different carbohydrates (Fig. S8). The different
simulations were performed with the anomer found in the
x-ray complex when available. Since these anomers are fixed
in silico, the anomer that was not used in the calculation wasBiophysical Journal 97(12) 3168–3177simply generated by exchanging the CH and COH groups of
the reducing carbon atom during the analysis. The three oligo-
saccharide compounds that exhibit a higher affinity show
amore compact clustering of the reducing terminal OHgroup,
indicating a better defined orientation in the active site. In
contrast, galacto-N-biose exhibits a more disperse distribu-
tion, which could be attributed to the configuration of the
4-hydroxyl group of the reducing sugar compared to its posi-
tion in lacto-N-biose (Fig. S1 and Fig. S2). The anomeric
configuration of the reducing sugar determines the orientation
of a third sugar moiety. In the case of lactose andN-acetyllac-
tosamine, extension of the disaccharide on the reducing end
with b- or a-linked sugars would lead to main interactions
with subsites D/E and C/D, respectively, whereas in the
case of lacto-N-biose, the opposite would be observed.
To confirm the results obtained from the MD simulations,
we used a combination of NMR and ITC experimental
methods.
NMR experiments
NMR is a useful technique for mapping the interaction site of
a ligand on a protein. In the case of galectin-1, a titration of the
complex formation with various carbohydrates gives one the
opportunity to observe the binding site in solution. The NMR
assignment of human galectin-1 was reported very recently
(28). A similar pattern was observed for the [1H-15N]
HSQC NMR spectra recorded on 6His-Gal-1, and therefore
the reported assignment was used to map galectin-1 residues
involved in the binding of the various carbohydrates.
NMR titrations of galectin-1 complexes with the various
oligosaccharides were carried out using HSQC experiments
in the absence and presence of galactose, lactose,N-acetyllac-
tosamine, lacto-N-biose, and galacto-N-biose (Fig. 5). Two
different types of effects induced by the five carbohydrates
were observed: galactose and galacto-N-biose had no effect10.0 9.0 8.0 7.0 1H (PPM)
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FIGURE 5 1H/15N HSQC spectra of galectin-1 (black)
in the presence of 10 excess of galactose (blue), lactose
(red), and N-acetyllactosamine (green). 6-His-galectin-1
was at 0.1 mM concentration in 10 mM sodium phosphate
buffer, pH 6.0. Residues showing significant variations are
indicated based on the recent assignment reported by Nes-
melova et al. (32). The color code for subsites A–E is the
same as in Fig. 1. Peaks circled by dotted lines were not as-
signed; they can correspond to Asn side chains near the
binding site (Asn-46 and Asn-61).
Galectin-1/Oligosaccharide Complexes 3175on galectin-1 NMR spectra up to 10 excesses, whereas the
presence of lactose, N-acetyllactosamine, and lacto-N-biose
induced significant variations in the NMR spectra. Residues
located in subsite C of galectin-1 (His-44, His-52, and
Trp-68) were affected in the presence of the three carbohy-
drates, with various chemical shift variations indicating
a different effect for the three molecules. Residues located
in the proximity of subsite D (Gly-53, Val-59, and Ser-62)
and in loops surrounding the binding site (Asn-39, Asn-40,
and Gly-66) were also affected by the presence of the ligands.
These chemical shift perturbations were attributed to residues
in proximity of the carbohydrate in the x-ray structures and
therefore corresponded to an equivalent mode of binding.
However, additional chemical shift variations were observed
corresponding to residues close to subsite B (Leu-34 and
Gly-35) that were not in direct contact with the carbohydrate
in the crystallographic structures. These data could be indica-
tive of indirect long-distance effects or of an alternate mode of
binding of the disaccharides in the CBS involving subsites B.
It has been suggested that a linear tetrasaccharide composed
of two lactose orN-acetyllactosamine subunits can be accom-
modated in the binding-site groove (21,36). One subunit
could interact with subsites C andD, as seen in the x-ray struc-
tures, and the other subunit could interact with additional
subsites A and B, as suggested by our NMR data. These
conclusions are supported by the recent structural character-
ization of human galectin-9 in the presence of poly-N-acetyl-
lactosamine, which revealed two putative modes of binding
(37). The comparison of the observed chemical shift varia-
tions for the different carbohydrates suggests a higher affinity
for N-acetyllactosamine than for lactose, and a poor affinity
for galacto-N-biose and galactose.
ITC
The binding of the different sugars with galectin-1 was inves-
tigated using ITC. The results of a typical experiment for the
binding of lactose are shown in Fig. 6. The complex formation
produced an exothermic heat of binding (Fig. 6, top),
providing a typical titration curve (Fig. 6, bottom). The exo-
thermic heat of interaction decreased regularly with succes-
sive injections until saturation was achieved. In agreement
with NMR experiments for galactose and galacto-N-biose,
the binding affinities were too low to determine the thermody-
namic parameters (Table 1). Lactose, N-acetyllactosamine,
and lacto-N-biose form a 2:1 complex with galectin-1 dimer
(one oligosaccharide per monomer). Affinity constants of
4896, 17067, and 6077M1 for lactose,N-acetyllactosamine,
and lacto-N-biose, respectively, are in good accordance with
the values reported previously in binding studies of different
carbohydrates with bovine heart galectin-1, murine recombi-
nant galectin-3, and human recombinant galectin-7 (38). The
interaction of galectin-1 with saccharide ligands is enthalpi-
cally driven and is counterbalanced by an unfavorable
entropic contribution. Such an enthalpy-entropy compensa-tion phenomenon agrees well with results obtained for lactose
andN-acetyllactosamine inwild-type hgalectin-1 and theC2S
and R111H mutants (17).
CONCLUSIONS
In this work, we used NMR and computational methods to
study galectin-1 binding to various oligosaccharide ligands.
The results of the MD simulations obtained with the different
saccharides allow for an interpretation of the binding affini-
ties measured by ITC and NMR experiments, and indicate
that it is possible to use MD simulations to discriminate
between ligands of high and low affinities, as was shown
previously for bovine galectin-1 (25). However, the interac-
tion energies computed are only qualitative. To precisely
calculate the binding energies, one would have to take into
account the solvation energies and entropy using methods
such as generalized Born (39) and normal-mode analyses,
which was beyond the scope of this study. In addition, ITC
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FIGURE 6 ITC experiment for galectin-1/lactose complex formation: heat
of binding (top) and binding isotherm (bottom). The titration was obtained
at 298 K for galectin-1 at 200 mM and 4 mL injections of 20 mM lactose in
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3176 Meynier et al.TABLE 1 Thermodynamic parameters obtained from ITC titrations
Ligand (mM) Ka (M1) DH (kJ.mol1) DG (kJ.mol1) TDS (kJ.mol1) n
Gal 200 <1000 11.85 0.7 – – 2.05 0.1
Lac 20 48965 439 33.95 3.3 21.05 0.3 12.95 3.0 2.25 0.7
LacNAc 20 170675 2002 26.35 0.8 24.15 0.3 2.2 5 0.5 1.95 0.2
NeoLac 20 60775 452 21.25 1.4 21.65 0.2 0.4 5 1.2 1.85 0.1
NeoGal 20 <1000 nd – – nd
Thermodynamic parameters of the binding determined from microcalorimetry experiments for galactose (Gal), lactose (Lac), N-acetyllactosamine (LacNAc),
lacto-N-biose (NeoLac), and galacto-N-biose (NeoGal). Values are the mean5 SE of three independent experiments.is a macroscopic method, and the existence of alternate
subsites of binding, as shown by x-ray for galectin-9 (37)
and NMR (this work), is a major limitation to correlating
MD simulation parameters and experimental data. MD simu-
lations using alternate binding modes as starting conforma-
tion, such as those observed with galectin-9, may be useful
to determine the contribution of each subsite to the affinity
of the carbohydrate ligands.
Our results show that the galactose monosaccharide itself
binds poorly to galectin-1, and a second monosaccharide
moiety (at least) on the reducing end is necessary to provide
a higher-affinity ligand. The interglycosidic linkage does
not appear to be essential, as both N-acetyllactosamine (1–4)
and lacto-N-biose (1–3) can interact with galectin-1. The
different linkages lead to different orientations of the sugar
in the CBS. However, the network of hydrogen bonds can
adapt to optimize the interaction due to the flexibility of
the saccharides. On the other hand, the nature of the reducing
sugar is crucial; among the four disaccharides analyzed, only
those containing a glucopyranose ring were able to bind effi-
ciently to galectin-1. The conformation of the galacto-N-
biose in the CBS led to a different orientation of the reducing
sugar that could not be stabilized by the network of hydrogen
bond. Finally, although no structural data were available for
the complex between galectin-1 and lacto-N-biose, we were
able to reproduce the efficient binding of this disaccharide.
We obtained our initial structure by superimposing the
nonreducing galactose moiety, which enabled us to study
the galactose-containing oligosaccharides without prior
knowledge of the 3D structure of the complex. Our approach
allowed us to define some key interactions between galec-
tin-1 and carbohydrate ligands that could serve as a starting
point for designing new drug protocols. For example, the
configuration of hydroxyl group at position 4 of the reducing
sugar plays a crucial role in the stabilization of the ligand in
the binding site.
Computational modeling of the sugar-lectin interaction
showed that binding sites accommodate more than one
carbohydrate subunit, i.e., they bind dimers and oligomers
as well as monomers. In the case of linear carbohydrate
chains, the free energy of binding often increases quickly
for the first few carbohydrate subunits, but then the further
addition of sugar subunits leads to only small increments
in binding energy (40). The N-acetyllactosamine (Galb1-
4GlcNAc) and lacto-N-biose (Galb1-3GlcNAc) disaccharideBiophysical Journal 97(12) 3168–3177moieties studied here are commonly found epitopes in
N-glycans; however, the nature of the subsequent sugars in
the glycan sequence is probably more associated with the
specificity of the ligand than with its affinity. MD simulation
is a promising approach to address this question because it
can be used to study the interaction between different
members of the galectin family and various oligosaccharides.
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